{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:16:12Z","timestamp":1783577772355,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ymgme.2021.08.006","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T23:49:52Z","timestamp":1629503392000},"page":"43-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Detecting lysosomal storage disorders by glycomic profiling using liquid chromatography mass spectrometry"],"prefix":"10.1016","volume":"134","author":[{"given":"Justin","family":"Mak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina M.","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2021.08.006_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijns3020006","article-title":"Newborn screening for lysosomal storage diseases: a concise review of the literature on screening methods, therapeutic possibilities and regional programs","volume":"3","author":"Schielen","year":"2017","journal-title":"Int. J. Neonatal Screen"},{"key":"10.1016\/j.ymgme.2021.08.006_bb0010","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/j.semperi.2015.03.005","article-title":"Newborn screening for lysosomal storage disorders","volume":"39","author":"Matern","year":"2015","journal-title":"Semin. Perinatol."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0015","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41436-018-0129-y","article-title":"The New York pilot newborn screening program for lysosomal storage diseases: report of the first 65,000 infants","volume":"21","author":"Wasserstein","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0020","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jpeds.2017.06.048","article-title":"Newborn screening for lysosomal storage disorders in Illinois: the initial 15-month experience","volume":"190","author":"Burton","year":"2017","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0025","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ymgme.2016.05.015","article-title":"Pilot study of newborn screening for six lysosomal storage diseases using Tandem mass spectrometry","volume":"118","author":"Elliott","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0030","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10545-017-0126-3","article-title":"Contribution of tandem mass spectrometry to the diagnosis of lysosomal storage disorders","volume":"41","author":"Piraud","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0035","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1479-7364-5-3-156","article-title":"Lysosomal storage disorders: molecular basis and laboratory testing","volume":"5","author":"Filocamo","year":"2011","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.ymgme.2021.08.006_bb0040","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jmoldx.2020.01.010","article-title":"Setup and validation of a targeted next-generation sequencing approach for the diagnosis of lysosomal storage disorders","volume":"22","author":"Zanetti","year":"2020","journal-title":"J. Mol. Diagnostics"},{"key":"10.1016\/j.ymgme.2021.08.006_bb0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ymgme.2020.04.006","article-title":"A comprehensive testing algorithm for the diagnosis of Fabry disease in males and females","volume":"130","author":"Stiles","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-9-59","article-title":"Assessment of a targeted resequencing assay as a support tool in the diagnosis of lysosomal storage disorders","volume":"9","author":"Fern\u00e1ndez-Marmiesse","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0055","first-page":"53","article-title":"Laboratory diagnosis of lysosomal diseases: newborn screening to treatment","volume":"41","author":"Fuller","year":"2020","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0060","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s10545-015-9843-7","article-title":"Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism","volume":"38","author":"Miller","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0065","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s11306-013-0582-1","article-title":"Validation of a dual LC\u2013HRMS platform for clinical metabolic diagnosis in serum, bridging quantitative analysis and untargeted metabolomics","volume":"10","author":"Gertsman","year":"2014","journal-title":"Metabolomics"},{"key":"10.1016\/j.ymgme.2021.08.006_bb0070","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10545-017-0131-6","article-title":"Next-generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients","volume":"41","author":"Coene","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0075","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10545-017-0129-0","article-title":"Fast and accurate quantitative organic acid analysis with LC-QTOF\/MS facilitates screening of patients for inborn errors of metabolism","volume":"41","author":"K\u00f6rver-Keularts","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0080","first-page":"1","article-title":"Integrated analysis of metabolomic profiling and exome data supplements sequence variant interpretation, classification, and diagnosis","author":"Alaimo","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0085","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/rcm.7860","article-title":"Development of a new tandem mass spectrometry method for urine and amniotic fluid screening of oligosaccharidoses","volume":"31","author":"Piraud","year":"2017","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0090","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1373\/clinchem.2018.289645","article-title":"UPLC-MS\/MS analysis of urinary free oligosaccharides for lysosomal storage diseases: diagnosis and potential treatment monitoring","volume":"64","author":"Huang","year":"2018","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0095","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ab.2005.06.042","article-title":"Profiling oligosaccharidurias by electrospray tandem mass spectrometry: quantifying reducing oligosaccharides","volume":"345","author":"Ramsay","year":"2005","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.aca.2016.06.054","article-title":"UPLC-MS\/MS detection of disaccharides derived from glycosaminoglycans as biomarkers of mucopolysaccharidoses","volume":"936","author":"Auray-Blais","year":"2016","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ymgme.2021.08.006_bb0105","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41436-018-0136-z","article-title":"Disease and subtype specific signatures enable precise diagnosis of the mucopolysaccharidoses","volume":"21","author":"Saville","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nchembio.766","article-title":"Disease-specific non\u2013reducing end carbohydrate biomarkers for mucopolysaccharidoses","volume":"8","author":"Lawrence","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ymgme.2013.06.007","article-title":"Newborn screening and diagnosis of mucopolysaccharidoses","volume":"110","author":"Tomatsu","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181700","article-title":"LC-MS\/MS multiplex analysis of lysosphingolipids in plasma and amniotic fluid: a novel tool for the screening of sphingolipidoses and Niemann-Pick type C disease","volume":"12","author":"Pettazzoni","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2021.08.006_bb0125","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1515\/cclm-2016-0340","article-title":"Diagnosis of sphingolipidoses: a new simultaneous measurement of lysosphingolipids by LC-MS\/MS","volume":"55","author":"Polo","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0130","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10545-015-9822-z","article-title":"Measurement of psychosine in dried blood spots \u2014 a possible improvement to newborn screening programs for Krabbe disease","volume":"38","author":"Turgeon","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0135","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1203\/01.PDR.0000141987.69757.DD","article-title":"Disease-specific markers for the mucopolysaccharidoses","volume":"56","author":"Fuller","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0140","first-page":"18","article-title":"Classification and regression by random forest","volume":"2","author":"Liaw","year":"2002","journal-title":"R News"},{"key":"10.1016\/j.ymgme.2021.08.006_bb0145","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1373\/clinchem.2012.201053","article-title":"Oligosaccharide analysis in urine by MALDI-TOF mass spectrometry for the diagnosis of lysosomal storage diseases","volume":"59","author":"Xia","year":"2013","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0150","series-title":"Waters Application Note","article-title":"Analysis of carbohydrates by ultra performance liquid chromatography and mass spectrometry","author":"Fountain","year":"2009"},{"key":"10.1016\/j.ymgme.2021.08.006_bb0155","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1016\/j.ymgme.2016.11.258","article-title":"Oligosacchariduria profiles by MALDI-TOF mass spectrometry and post-analytical interpretation using multivariate pattern recognition software","volume":"120","author":"Nickander","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0160","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ymgme.2018.03.002","article-title":"Urine oligosaccharide screening by MALDI-TOF for the identification of NGLY1 deficiency","volume":"124","author":"Hall","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0165","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1086\/302948","article-title":"A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency","volume":"66","author":"De Praeter","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0170","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1373\/clinchem.2011.178319","article-title":"Rapid ultraperformance liquid chromatography-tandem mass spectrometry assay for a characteristic glycogen-derived tetrasaccharide in pompe disease and other glycogen storage diseases","volume":"58","author":"Sluiter","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21197159","article-title":"Value of glucosylsphingosine (Lyso-Gb1) as a biomarker in gaucher disease: a systematic literature review","volume":"21","author":"Revel-Vilk","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0114669","article-title":"Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for niemann-pick disease type C in a retrospective study","volume":"9","author":"Welford","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2021.08.006_bb0185","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1515\/cclm-2018-1301","article-title":"Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: a comparative study","volume":"57","author":"Polo","year":"2019","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0190","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/gim.2018.31","article-title":"Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis","volume":"21","author":"Maruyama","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0195","first-page":"1","article-title":"Clinical validation of targeted and untargeted metabolomics testing for genetic disorders: a 3 year comparative study","volume":"10","author":"Almontashiri","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0200","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1089\/gtmb.2015.0291","article-title":"Metabolomic profiling of human urine as a screen for multiple inborn errors of metabolism","volume":"20","author":"Kennedy","year":"2016","journal-title":"Genet. Test. Mol. Biomark."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0205","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2215\/CJN.07070618","article-title":"Variability of two metabolomic platforms in CKD","volume":"14","author":"Rhee","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/metabo9120289","article-title":"Untargeted metabolomics-based screening method for inborn errors of metabolism using semi-automatic sample preparation with an UHPLC-orbitrap-MS platform","volume":"9","author":"Bonte","year":"2019","journal-title":"Metabolites"},{"key":"10.1016\/j.ymgme.2021.08.006_bb0215","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cca.2017.09.024","article-title":"Urinary metabolic phenotyping of mucopolysaccharidosis type I combining untargeted and targeted strategies with data modeling","volume":"475","author":"Zerimech","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2021.08.006_bb0220","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3390\/ijms20020446","article-title":"Analysis of mucopolysaccharidosis type VI through integrative functional metabolomics","volume":"20","author":"Tebani","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-018-1625-1","article-title":"Unveiling metabolic remodeling in mucopolysaccharidosis type III through integrative metabolomics and pathway analysis","volume":"16","author":"Tebani","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ymgme.2021.08.006_bb0230","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s11011-017-0009-1","article-title":"Serum global metabolomics profiling reveals profound metabolic impairments in patients with MPS IIIA and MPS IIIB","volume":"32","author":"Fu","year":"2017","journal-title":"Metab. Brain Dis."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221007708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221007708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:52:03Z","timestamp":1761090723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719221007708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":46,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1096719221007708"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.08.006","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detecting lysosomal storage disorders by glycomic profiling using liquid chromatography mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}